On April 20, six expert physicians from various Indonesian provinces—including Dr. Salomo from North Sumatra, Dr. Laili from Java, and Dr. Eliyanti from South Sulawesi—visited Dier Biotechnology for an inspection tour, accompanied by local distributors. Mr. Lin Huaqing, Chairman of Zhuhai Dier Bioengineering Co., Ltd., led the delegation and extended a warm welcome.

Mr. Lin Huaqing first extended a warm welcome to Dr. Salomo and his delegation, and provided the visiting group with an overview of Dier Biotech, its development journey, and its current market size. He then gave a detailed presentation on Dier Biotech’s existing automated clinical microbiology testing systems and associated reagents, and shared the company’s future product roadmap. The visiting clients expressed high praise for Dier Biotech’s progress.

Subsequently, the Indonesian delegation, accompanied by Chairman Lin, toured Dier Bio’s exhibition hall and production facilities. They expressed admiration for Dier Bio’s diversified product portfolio, its clean‑room manufacturing environment that meets international standards, and its highly specialized, automated production lines. Indonesian expert Salomo noted that he had previously known little about Chinese‑made medical devices, and that local healthcare institutions rarely used them. However, over the past decade and a half, he has witnessed China’s rapid and remarkable development, and the emergence of numerous Chinese brands has convinced him of the significant improvement in the quality of Chinese manufacturing. In 2016, Dr. Salomo trialed blood culture bottles produced by Dier Bio, whose outstanding performance earned widespread recognition. Following this visit, his confidence in Chinese brands—and in Dier Bio—has been further strengthened. He also stated that he will work closely with local distributors and Dier Bio to promote the company’s microbial‑testing products in Indonesia, thereby enhancing the region’s capabilities in infection diagnostics and bacterial resistance monitoring.